Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Determinants of peak V(O2) in peripheral arterial occlusive disease patients.
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb Res. 2004; 113(5):333-9.
View in:
PubMed
subject areas
Aprotinin
Drug Evaluation, Preclinical
Hemostasis
Humans
In Vitro Techniques
Kallikreins
Oligopeptides
Partial Thromboplastin Time
Prothrombin Time
Recombinant Proteins
Thrombelastography
Thrombin
Whole Blood Coagulation Time
authors with profiles
Kenichi Tanaka